Factors other than hTau overexpression that contribute to tauopathy-like phenotype in rTg4510 mice
Related Experiment Video
Updated: Jan 23, 2026

In vivo Reprogramming of Adult Somatic Cells to Pluripotency by Overexpression of Yamanaka Factors
Published on: December 17, 2013
Julia Gamache1, Kellie Benzow2, Colleen Forster3
1Department of Neurology, N. Bud Grossman Center for Memory Research and Care, Minneapolis, MN, USA.
Abstract:
The tauopathy-like phenotype observed in the rTg4510 mouse line, in which human tauP301L expression specifically within the forebrain can be temporally controlled, has largely been attributed to high overexpression of mutant human tau in the forebrain region. Unexpectedly, we found that in a different mouse line with a targeted-insertion of the same transgene driven by the same tetracycline-TransActivator (tTA) allele, but with even higher overexpression of tauP301L than rTg4510, atrophy and tau histopathology are delayed, and a different behavioral profile is observed. This suggests that it is not overexpression of mutant human tau alone that contributes to the phenotype in rTg4510 mice. Furthermore we show that the tauopathy-like phenotype seen in rTg4510 requires a ~70-copy tau-transgene insertion in a 244 kb deletion in Fgf14, a ~7-copy tTA-transgene insertion in a 508 kb deletion that disrupts another five genes, in addition to high transgene overexpression. We propose that these additional effects need to be accounted for in any studies using rTg4510.
Insights
High overexpression of mutant human tau alone does not cause tauopathy. Genetic background and transgene insertion site significantly influence tauopathy-like phenotypes in mouse models.
Area of Science:
- Neuroscience
- Genetics
- Pathology
Background:
- The rTg4510 mouse line exhibits a tauopathy-like phenotype attributed to high forebrain expression of mutant human tau (tau P301L).
- Temporal control of transgene expression is a feature of this model.
Purpose of the Study:
- To investigate the sole contribution of mutant human tau overexpression to tauopathy-like phenotypes.
- To identify other genetic factors influencing tauopathy in the rTg4510 mouse line.
Main Methods:
- Comparison of tau P301L overexpression levels and phenotypes between rTg4510 mice and a novel mouse line with targeted transgene insertion.
- Analysis of transgene insertion sites, copy numbers, and associated genomic deletions in rTg4510 mice.
Main Results:
- A novel mouse line with higher tau P301L overexpression than rTg4510 showed delayed atrophy and distinct behavioral profiles.
- The tauopathy phenotype in rTg4510 mice is linked to a large deletion in Fgf14 and a separate deletion disrupting five genes, in addition to transgene overexpression.
- The number of tau transgene copies and the specific insertion locus are critical factors.
Conclusions:
- Mutant human tau overexpression alone is insufficient to fully explain the rTg4510 tauopathy phenotype.
- The genetic background, including large genomic deletions and transgene insertion site, significantly modulates tauopathy development.
- Future studies using rTg4510 must consider these confounding genetic factors for accurate interpretation.
Related Concept Videos
Binet's Contribution to Measures of Intelligence
Wechsler's Contribution to Measures of Intelligence
Transcription Factors
Factors Affecting Solubility
Transcription Elongation Factors
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
Factors Affecting Drug Distribution: Miscellaneous Factors
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...

